352 related articles for article (PubMed ID: 33914926)
1. A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.
Lavery MJ; Nawimana S; Parslew R; Stewart L
Clin Exp Dermatol; 2021 Oct; 46(7):1325-1327. PubMed ID: 33914926
[No Abstract] [Full Text] [Related]
2. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
Petruzzi M; Galleggiante S; Messina S; Della Vella F
BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
[TBL] [Abstract][Full Text] [Related]
3. Viral-like Reaction or Hypersensitivity? Erythema Multiforme Minor Reaction and Moderate Eosinophilia After the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 Vaccine.
de Las Vecillas L; López J; Morchón E; Rodriguez F; Drake M; Martino M
J Investig Allergol Clin Immunol; 2021 Feb; 32(1):77-78. PubMed ID: 34588156
[No Abstract] [Full Text] [Related]
4. Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination.
Gambichler T; Scholl L; Dickel H; Ocker L; Stranzenbach R
J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e415-e416. PubMed ID: 33725406
[No Abstract] [Full Text] [Related]
5. [Erythema multiforme following COVID-19 vaccination (BNT162b2)].
Wunderlich K; Dirschka T
Hautarzt; 2022 Jan; 73(1):68-70. PubMed ID: 34676438
[TBL] [Abstract][Full Text] [Related]
6. Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.
Buján Bonino C; Moreiras Arias N; López-Pardo Rico M; Pita da Veiga Seijo G; Rosón López E; Suárez Peñaranda JM; Sánchez-Aguilar Rojas D
Int J Dermatol; 2021 Nov; 60(11):e466-e467. PubMed ID: 34473839
[No Abstract] [Full Text] [Related]
7. Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.
Sechi A; Pierobon E; Pezzolo E; Germi L; Trevisan G; Zardo D; Riva G; Mondino S; Naldi L
Clin Exp Dermatol; 2022 Feb; 47(2):437-440. PubMed ID: 34617317
[No Abstract] [Full Text] [Related]
8. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Updates: Pfizer-BioNTech COVID-19 vaccine.
Med Lett Drugs Ther; 2022 Jan; 64(1642):16. PubMed ID: 35134045
[No Abstract] [Full Text] [Related]
10. Erythema Multiforme Induced by Zonisamide and Triggered by the First Dose of COVID-19 Vaccine (Pfizer-BioNTech).
Murata T; Nobukuni Y
Am J Ther; 2023 May; 30(3):e261-e265. PubMed ID: 37278706
[No Abstract] [Full Text] [Related]
11. COVID-19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast.
Pacifico A; d'Arino A; Pigatto PDM; Malagoli P; Young Dermatologists Italian Network ; Damiani G
Clin Exp Dermatol; 2021 Oct; 46(7):1344-1346. PubMed ID: 33969530
[No Abstract] [Full Text] [Related]
12. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.
Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM
Front Immunol; 2021; 12():728021. PubMed ID: 34646267
[TBL] [Abstract][Full Text] [Related]
13. Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme.
Borg L; Mercieca L; Mintoff D; Micallef D; Pisani D; Betts A; Scerri L
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e22-e24. PubMed ID: 34547125
[No Abstract] [Full Text] [Related]
14. Efficacy of intravitreal dexamethasone in the treatment of frosted branch angiitis after mRNA-based COVID-19 vaccine.
Koc H; Ozen S
J Fr Ophtalmol; 2024 May; 47(5):104002. PubMed ID: 37919147
[No Abstract] [Full Text] [Related]
15. Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech).
Kim MJ; Kim JW; Kim MS; Choi SY; Na JI
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e98-e100. PubMed ID: 34661942
[No Abstract] [Full Text] [Related]
16. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
[TBL] [Abstract][Full Text] [Related]
17. Pityriasis lichenoides chronica after BNT162b2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV-2 vaccine.
Drago F; Ciccarese G; Guadagno A; Parodi A
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e979-e981. PubMed ID: 35841285
[No Abstract] [Full Text] [Related]
18. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
[TBL] [Abstract][Full Text] [Related]
19. Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years.
Eliakim-Raz N; Leibovici-Weisman Y; Stemmer A; Ness A; Awwad M; Ghantous N; Stemmer SM
JAMA; 2021 Dec; 326(21):2203-2204. PubMed ID: 34739043
[TBL] [Abstract][Full Text] [Related]
20. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.
Tarawneh O; Tarawneh H
Am J Hematol; 2021 May; 96(5):E133-E134. PubMed ID: 33476455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
